F | Musculoskeletal Oncology
- PMID: 36327369
- Bookshelf ID: NBK585946
F | Musculoskeletal Oncology
Excerpt
The impact of bone tumours on clinical practice remains as large today as it was at the turn of the century and as it is likely to remain so for several decades more. Bone and soft tissue cancers create challenges for patients that are not seen in most other malignancies, such as changes in gait, function, stability, strength, and appearance. Moreover, the economic burden can be great: the more advanced the disease at diagnosis, the worse the prognosis and, accordingly, the more expensive the treatments. This chapter of the White Book on Tumours aims to present an impartial review and a comprehensive overview of the current healthcare situation for patients with bone tumours in Europe.
Copyright The Editor(s) (if applicable) and The Author(s) 2021. This book is an Open-Access-Publication.
Sections
References
-
- Cappellari A, Trovarelli G, Crimì A, Pala E, Angelini A, Berizzi A, Ruggieri P. New concepts in the surgical treatment of actual and impending pathological fractures in metastatic disease. Injury. 2020 Nov 11; S0020-1383(20)30952-9. - PubMed
-
- Cetin K, Christiansen CF, Jacobsen JB, Nørgaard M, Sørensen HT. Bone metastasis, skeletal-related events, and mortality in lung cancer patients: a Danish population-based cohort study. Lung Cancer. 2014 Nov;86(2):247–54. - PubMed
-
- Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:6243s–6249s. - PubMed
Publication types
LinkOut - more resources
Full Text Sources